Prevention of Everolimus/Exemestane
Stomatitis in Postmenopausal Women With
Hormone Receptor–Positive Metastatic
Breast Cancer Using a Dexamethasone-
Based Mouthwash: Results of the SWISH Trial
Hope S Rugo,
1
Lasika Seneviratne,
2
J Thaddeus Beck,
3
John A Glaspy,
4
Julio A Peguero,
5
Timothy J Pluard,
6
Navneet Dhillon,
7
Leon Christopher Hwang,
8
Chaitali Nangia,
9
Ingrid A Mayer,
10
Timothy F Meiller,
11
Mark S Chambers,
12
Ghulam Warsi,
13
Robert W Sweetman,
13
J Randy Sabo,
13
Jennifer K Litton
12
1
University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California;
2
Los Angeles
Cancer Network, Los Angeles, California;
3
Highlands Oncology Group, Fayetteville, Arkansas;
4
University of California Los Angeles
School of Medicine, Los Angeles, California;
5
Oncology Consultants PA, Houston, Texas;
6
St. Luke’s Cancer Institute, Kansas City,
Missouri;
7
Cancer Treatment Centers of America, Atlanta, Georgia;
8
Kaiser Permanente Mid-Atlantic States, Gaithersburg, Maryland;
9
University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange, California;
10
Vanderbilt-Ingram
Comprehensive Cancer Center, Nashville, Tennessee;
11
Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart
Greenebaum Cancer Center University of Maryland Medical Center, Baltimore, Maryland;
12
The University of Texas MD Anderson
Cancer Center, Houston, Texas;
13
Novartis Pharmaceuticals Corporation, East Hanover, New Jersey
